Pharmacotherapy of conduct disorder: Challenges, options and future directions.

about

Pharmacotherapy of conduct disorder: Challenges, options and future directions.

Item

http://www.wikidata.org/entity/Q38839950

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Pharmacotherapy of conduct disorder: Challenges, options and future directions.

@en

type

Item

label

Pharmacotherapy of conduct disorder: Challenges, options and future directions.

@en

prefLabel

Pharmacotherapy of conduct disorder: Challenges, options and future directions.

@en

P1476

Pharmacotherapy of conduct disorder: Challenges, options and future directions

@en

P2093

Alison Haywood

http://www.w3.org/2001/XMLSchema#string

Brett McDermott

http://www.w3.org/2001/XMLSchema#string

Jessica L Hambly

http://www.w3.org/2001/XMLSchema#string

Sohil Khan

http://www.w3.org/2001/XMLSchema#string

P2860

Melatonin Treatment for Insomnia in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder

Atypical antipsychotics for disruptive behaviour disorders in children and youths

Emerging pharmacotherapies for neurodevelopmental disorders

The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-a

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats

Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorder

Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder

A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.

P304

967-975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0269881116658985

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

William Bor

P577

2016-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27436231

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy